Rivest S, Torres G, Rivier C
Clayton Foundation Laboratories for Peptide Biology, Salk Institute, La Jolla, CA 92037.
Brain Res. 1992 Jul 31;587(1):13-23. doi: 10.1016/0006-8993(92)91424-d.
Cytokines such as interleukin-1 beta (IL-1 beta) alter the activity of the hypothalamic-pituitary-adrenal (HPA) and hypothalamic-pituitary-gonadal (HPG) axes in the rat. However, the brain sites at which IL-1 beta exerts these effects have not been well identified. The present study sought to identify some of these sites, using c-fos protein expression as an index of cellular activation. We also attempted to determine possible differences between the effects of peripheral and central injection of IL-1 beta on the activation of specific brain areas. Castrated male rats received intravenous (i.v.) or intracerebroventricular (i.c.v.) injections of IL-1 beta through a jugular catheter or a permanent cannula implanted in the right lateral ventricle, respectively. Blood samples were taken before, as well as 30 and 120 min after i.v. or i.c.v. IL-1 beta infusion in order to measure plasma ACTH and LH levels. Immediately thereafter, the rats were anesthetized with pentobarbital, then perfused. Their brains were removed and postfixed for one hour. Thirty-microns frozen sections were cut and approximately every fourth tissue section was processed for c-fos expression by an avidin-biotin-peroxidase method. Both i.v. (1 microgram) and i.c.v. (100 ng) injection of IL-1 beta significantly increased plasma ACTH levels, but only i.c.v. treatment measurably inhibited LH secretion. I.c.v. infusion of the cytokine markedly augmented c-fos expression in the paraventricular nucleus (PVN) and the arcuate nucleus (ARC) of the hypothalamus. A large amount of CRF cells in the PVN contained labelled c-fos protein (as measured by a double labelling technique), which indicates that CRF perikarya in this hypothalamic region are activated by the central administration of IL-1 beta. In contrast, i.v. injection of IL-1 beta did not significantly alter c-fos expression in the PVN or the ARC of the hypothalamus. These results suggest that the increased HPA axis activity which follows the peripheral IL-1 beta administration, a phenomenon previously shown to depend on endogenous CRF, does not require immediate activation of hypothalamic CRF perikarya. Thus our results indicate that the stimulatory effect of blood-born cytokine may be exerted at the level of nerve terminals in the median eminence. In contrast, i.c.v.-injected IL-1 beta appears to activate the HPA axis through a stimulation of CRF neurons within the parvocellular part of PVN.(ABSTRACT TRUNCATED AT 400 WORDS)
细胞因子如白细胞介素-1β(IL-1β)可改变大鼠下丘脑-垂体-肾上腺(HPA)轴和下丘脑-垂体-性腺(HPG)轴的活性。然而,IL-1β发挥这些作用的脑区尚未得到很好的确定。本研究试图利用c-fos蛋白表达作为细胞活化指标来确定其中一些脑区。我们还试图确定外周注射和脑室内注射IL-1β对特定脑区活化作用的可能差异。去势雄性大鼠分别通过颈静脉导管或植入右侧脑室的永久性套管接受静脉内(i.v.)或脑室内(i.c.v.)注射IL-1β。在静脉内或脑室内注射IL-1β之前、30分钟和120分钟后采集血样,以测量血浆促肾上腺皮质激素(ACTH)和促黄体生成素(LH)水平。此后立即用戊巴比妥麻醉大鼠,然后进行灌注。取出它们的大脑并后固定1小时。切成30微米的冰冻切片,大约每隔四张组织切片用抗生物素蛋白-生物素-过氧化物酶法处理以检测c-fos表达。静脉内(1微克)和脑室内(100纳克)注射IL-1β均显著提高血浆ACTH水平,但只有脑室内注射可测量地抑制LH分泌。脑室内注入该细胞因子显著增强下丘脑室旁核(PVN)和弓状核(ARC)中的c-fos表达。PVN中大量促肾上腺皮质激素释放因子(CRF)细胞含有标记的c-fos蛋白(通过双重标记技术测量),这表明该下丘脑区域的CRF神经元胞体被脑室内注射IL-1β激活。相反,静脉内注射IL-1β并未显著改变下丘脑PVN或ARC中的c-fos表达。这些结果表明,外周给予IL-1β后HPA轴活性增加这一先前表明依赖内源性CRF的现象,并不需要下丘脑CRF神经元胞体立即激活。因此我们的结果表明,血液中细胞因子的刺激作用可能在正中隆起的神经末梢水平发挥。相反,脑室内注射的IL-1β似乎通过刺激PVN小细胞部内的CRF神经元来激活HPA轴。(摘要截短至400字)